Preclinical Characterization of Anti-SIRPα mAb BYON4228 Published in Journal for ImmunoTherapy of Cancer

Byondis B.V. announced that the Journal for ImmunoTherapy of Cancer has published encouraging preclinical data on its investigational monoclonal antibody BYON4228.